Kyverna Therapeutics Inc. (KYTX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kyverna Therapeutics Inc.

    NASDAQ: KYTX · Real-Time Price · USD
    5.52
    -0.56 (-9.21%)
    At close: Oct 03, 2025, 3:59 PM
    5.54
    0.36%
    After-hours: Oct 03, 2025, 07:59 PM EDT

    Kyverna Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.12 -334.77 -26.79 -29.38
    PEG Ratio
    		 -0.00 3.35 -2.73 n/a
    PS Ratio
    		 n/a n/a 110.19 136.87
    PB Ratio
    		 0.54 410.94 -10.46 -16.74
    P/FCF Ratio
    		 -1.23 -381.07 -20.99 -33.02
    P/OCF Ratio
    		 -1.25 -385.59 -21.44 -34.94
    OCF/S Ratio
    		 n/a n/a -5.14 -3.92
    Debt / Equity Ratio
    		 0.03 0.18 -0.14 -0.12
    Quick Ratio
    		 8.61 3.05 4.45 4.84
    Current Ratio
    		 8.61 3.05 4.45 4.84
    Asset Turnover
    		 n/a n/a 0.10 0.07
    Interest Coverage
    		 -1K -333.72 -452.06 -8.78K
    Return on Equity
    		 -0.48 -1.23 0.39 0.57
    Return on Assets
    		 -0.42 -0.8 -0.43 -0.31
    Return on Invested Capital
    		 -0.51 -1.07 -0.51 -0.37
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a 0.85 0.90
    Net Profit Margin
    		 n/a n/a -4.11 -4.66
    Pretax Profit Margin
    		 n/a n/a -4.11 -4.66
    Operating Profit Margin
    		 n/a n/a -4.18 -4.66
    FCF Margin
    		 n/a n/a -5.25 -4.14
    EBITDA Margin
    		 n/a n/a -3.95 -4.55

    Add to Watchlist